Literature DB >> 28769026

Chemical Composition, Antioxidant, Anti-Inflammatory, and Antiproliferative Activities of the Plant Lebanese Crataegus Azarolus L.

Hany Kallassy1,2, Mohammad Fayyad-Kazan3, Rawan Makki1, Yolla El-Makhour4, Eva Hamade1, Hasan Rammal5, David Y Leger2, Vincent Sol2, Hussein Fayyad-Kazan1, Bertrand Liagre2, Bassam Badran1.   

Abstract

BACKGROUND In the present study, phytochemical screening, antioxidant, anti-inflammatory, and antiproliferative capacities of 3 extracts from leaves of Lebanese Crataegus azarolus L. were evaluated. MATERIAL AND METHODS Fresh leaves were dissolved in 3 different solvents: distilled water, ethanol, and methanol. The chemical composition was determined using high-performance liquid chromatography (HPLC) and the content of essential oil of this plant was examined by gas chromatography (GC) coupled with mass spectrometry (MS). The antioxidant potential was evaluated using DPPH radical scavenging and Fe2+ chelating activity assays. Anti-inflammatory effect was investigated by measuring the secreted amounts of the proinflammatory mediator PGE2 using ELISA technique, as well as by assaying the mRNA levels of the proinflammatory cytokines (IL-α, IL-β, and Il-6), chemokines (CCL3 and CCL4) and inflammation-sensitive COX2 and iNOS enzymes using quantitative real-time PCR (qRT-PCR). The antiproliferative effect was evaluated using the XTT viability assay. RESULTS The obtained results show that alcohol (methanol and ethanol) extracts were rich in bioactive molecules with medical relevance and exerted substantial antioxidant, anti-inflammatory, and antiproliferative capacities. On the other hand, aqueous extract contained fewer chemical components and exhibited less therapeutic efficiency. CONCLUSIONS Our observations indicate that Crataegus azarolus L. could be used for treating diseases related to oxidative stress, inflammatory reactions, and uncontrolled cell growth.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28769026      PMCID: PMC5553438          DOI: 10.12659/msmbr.905066

Source DB:  PubMed          Journal:  Med Sci Monit Basic Res        ISSN: 2325-4394


Background

It is well established that reactive oxygen species (ROS), such as superoxide (O2−) and hydrogen peroxide (H2O2), as well as reactive nitrogen species (RNS), including nitric oxide (NO) and nitric dioxide (NO2), play a dual role as both beneficial and deleterious chemical components. When present in moderate amounts, ROS and RNS could play a beneficial role upon serving as signaling messengers regulating a number of physiological processes, including gene expression, cell growth, and orchestration of immune responses [1-4]. However, excess of these reactive molecules generates oxidative stress, a harmful process that can damage all biological macromolecules and cell structures [4-7]. Oxidative stress is generally considered as a risk factor triggering the development of various critical pathologies, including cancer, arthritis, atherosclerosis, diabetes, autoimmune disorders, and cardiovascular and neurodegenerative diseases [8,9]. Endogenous antioxidants (fabricated by the body), as well as exogenous ones (supplied through diet), are chemicals that interact with and neutralize the ROS and RNS molecules, thus preventing their toxic effect [8,10]. Historically, plants are well known for their medicinal value, mainly related to their phytochemical component content, including phenolic compounds, flavonoids, alkaloids, tannins, and other stress-responsive products [11-14]. Indeed, plant-derived antioxidants, especially polyphenolic compounds, have proven success in minimizing the levels of toxic free radicals and relieving different oxidative stress-mediated diseases [13,15,16]. In addition, daily intake of natural antioxidants has been correlated with reduced occurrence of different diseases, including cancer, diabetes, and cardiovascular diseases [17]. Moreover, the phenolics and flavonoids of various medicinal plants exhibit potent anti-inflammatory and antiproliferative capacities [12,18-20]. Crataegus (Hawthorn), belonging to the Rosacea family, comprises about 280 species that are mainly distributed in the northern temperate zones of North America, East Asia, Central Asia, and Europe [21]. Interestingly, hawthorn fruits have long been used in traditional medicine to treat different health concerns, mainly those related to the heart and blood vessels [22]. The pharmacological potential of hawthorn has been attributed to its important chemical composition, including proanthocyanidins, flavonoids, tannins, vitamin C, and glycosides [21,23]. Although the chemistry of different Crataegus species has already been described, the chemical composition of many other species is yet to be characterized. Crataegus, known as Zaarour in Lebanon, is represented by 3 species in the Lebanese flora: C. azarolus L., C. monogyna (Jacq), and C. sinaica (Boiss). So far, neither analytical nor biological studies have been performed on the Lebanese Crataegus species. In this study, we characterized the phytochemical component content, antioxidant, anti-inflammatory, and antiproliferative capacities of 3 extracts (water, ethanolic, and methanolic) prepared from fresh leaves of Crataegus azarolus L. grown in Lebanon.

Material and Methods

Plant collection and preparation of powders

Fresh leaves were gathered from southern Lebanon at 350 m altitude in spring season between March and May in 2011, and the biological authentication was carried out by Professor George Tohme, president of CNRS of Lebanon. After harvesting, they were well washed, cut into small pieces, and dried in the shade at room temperature, away from sunlight. After this period, the dried leaves were crushed and ground to a homogeneous fine powder by use of a grinder and then kept in the dark at room temperature until use in different studies.

Apparatus and chemicals

All of the used chemicals were of analytical grade. Absolute ethanol, methanol, n-hexane, sodium hydroxide, ethyl acetate, and dichloromethane were purchased from BDH England. Aluminium chloride and FeSO4•7H2O, silica gel was purchased from Merck Germany. Sodium carbonate and hydrogen peroxide were purchased from Unichem India. Ascorbic acid, gallic acid, rutin, Folin-Ciocalteau reagent, EDTA, ferrozine, and DPPH were purchased from Sigma Aldrich, USA. PBS was purchased from Gibco, UK. MS spectra were recorded on an Agilent series device and MSMS spectra were recorded on a Shimadzu series device.

Preparation of crude extracts using water, ethanol, and methanol as solvents

Powdered leaves (100 g) were deposited into a flask with 500 ml of the selected solvent (distilled water, ethanol, or methanol). After a period of maceration and stirring for 1 week at room temperature, the macerate was collected and filtered using filter paper. Extracts were then concentrated using a rotary evaporator at 40°C under reduced pressure (for ethanol and methanol extracts). The aqueous extract was prepared using the same steps as the alcoholic extraction except the temperature of the extraction was 60°C and the filtrates were then frozen before being lyophilized to obtain powders.

Phytochemical screening

To determine the chemical composition of the different extracts from leaves of C. azarolus, qualitative tests were done to detect the presence of primary and secondary metabolites as shown in Table 1. These tests are useful to estimate biological activities that might be due to the presence of secondary metabolites in the leaves of this plant.
Table 1

Detection of primary and secondary metabolites in leaves of Crataegus azarolus L.

MetabolitesAdded reagentExpected result
Alkaloids [36]Dragendorff reagentRed or Orange precipitate
Tanins [36]FeCl3 (1%)Blue coloration
Resines [36]Acetone + waterTurbidity
Saponines [37]AgitationFormation of foam
Phenols [36]FeCl3 (1%) + K3(Fe(CN)6) (1%)Green-blue coloration
Terpenoids [37]Chloroform + H2SO4 concReddish brown coloration
Flavonoids [38]KOH (50%)Yellow coloration
Carbohydrates [37]α-naphtol + H2SO4Purple ring
Reducing sugars [37]Fehlings (A+B)Brownish-red precipitate
Quinones [39]HCl concYellow precipitate
Sterols & steroids [37,38]Chloroform + H2SO4 concRed color (surface) + fluorescence Greenish-yellow
Cardiac glycosides [37,38]Glacial acetic acid + FeCl3 (5%) + H2SO4 concRing
Diterpenes [36]Copper acetateGreen coloration
Anthraquinones [38]HCl (10%) + chloroform + Ammonia (10%)Pink coloration
Proteins & aminoacids [40]Ninhydrin 0.25%Blue coloration
Lignines [40]SafraninePink coloration
Phlabotannins [41]HCl (1%)Blue coloration
Anthocyanines [42]NaOH (10%)Blue coloration
Flavanones [42]H2SO4 concBluish-red Coloration
Fixed oils and fats [37]Spot TestOil stain

Gas chromatography – mass spectrometry (GC/MS) analysis

The GC/MS analysis was performed on an Agilent 7890A-GCMS device. In the separation and identification by GC/MS technique, components were identified on the basis of the retention time and spectral index from the NIST and WILEY library. The instrument specifications and analysis conditions adjusted are given below in Tables 2 and 3.
Table 2

The instrument specifications and analysis conditions for water extracts.

GC Program
Oven Maximum Temperature325 °C
Hold time1 min
Post Run50 c
Program8c/min – 290 c – 11 min
Equilibration Time3 min
Injection volume1 μl
Front SS Inlet ModeSplit
Injector temperature280 °C
Pressure52.76 psi
Total Flow6 ml/min
Split Ratio5: 1
Split Flow5 ml/min
ColumnDB-5MS: 30 m×250 μm×0.25 μm
MS Source230 c maximum 250 c
MS Quad150 c maximum 200 c
Acquisition ModeScan
Solvent Delay2.5 min
Low Mass33
High Mass500
Table 3

The instrument specifications and analysis conditions for methanol and ethanol extracts.

GC Program
Oven Temperature Set point35°C
Hold time2 min
Post Run60 c
Program3 c/min – 320 c – 1 min
Equilibration Time0.5 min
Injection volume1 μl
Back SS Inlet ModeSplit
Injector temperature300 °C
Pressure11.192 psi
Total Flow504 ml/min
Split Ratio500: 1
Split Flow500 ml/min
ColumnTG-5MS: 30 m×250 μm×0.25 μm
MS Source230 c maximum 250 c
MS Quad150 c maximum 200 c
Acquisition ModeScan
Solvent Delay2 min
Low Mass1.6
High Mass450

Liquid chromatography – mass spectrometry (LC/MS/MS) analysis

The LC/MS/MS analysis was performed on a Shimadzu-AB Sciex LCMSMS device for the detection. In the separation and identification by LC/MS/MS technique, components were identified on the basis of the retention time and mass spectral characteristics. The instrument specifications and analysis conditions adjusted are given below in Table 4.
Table 4

The instrument specifications and analysis conditions.

HPLC/PumpShimadzu/LC20AD
Mass spectrometerAPI 4000/AB Sciex instruments
Component NameTriple Quadrupole LC/MS/MS Mass Spectrometer
Source Temperature (at set point)300°C
LC system Equilibration time2 min
LC system Injection Volume10 μl
Pumping ModeLow pressure Gradient:Time (min) Module Events Parameter0.01 Pumps ACN+ 0.1% Formic acid 0.00.10 Pumps ACN+ 0.1% Formic acid 206.00 Pumps ACN+ 0.1% Formic acid 909.00 Pumps ACN+ 0.1% Formic acid 909.50 Pumps ACN+ 0.1% Formic acid 012.00 System Controller Stop
Total Flow0.3 ml/min
Autosampler modelSIL-20A/HT
ColumnC18 (15 cm*0.2 mm*3.5 um)

Biological activities

DPPH radical scavenging assay

The antioxidant activity was assessed according to the method of Farhan et al. [24] using free radical DPPH. Increasing concentrations of extracts (0.05, 0.1, 0.2, 0.4, and 0.5 mg/ml) were prepared. We added 1 ml of each prepared dilution of each extract to 1 ml of DPPH reagent [0.15 mM]. The solutions were incubated in the dark at room temperature for 30 min and the absorbance was measured at 517 nm using a Gene Quant 1300 UV-Vis spectrophotometer. The DPPH-scavenging ability of leaf extracts was calculated according to the following equation: The control was prepared by mixing 1 ml DPPH with 1 ml of selected solvent. The blank was composed of 1 ml of the selected solvent.

Metal chelating activity

The chelation of ferrous ions by extracts was estimated by the method of Dinis et al. [24]. Briefly, 50 μl of FeCl2 (2 mM) was added to 1 ml of different concentrations of the extract (500, 750, 1000, 1250, and 1500 μg/ml). The reaction was initiated by the addition of 0.2 ml of ferrozine solution (5 mM). The mixture was vigorously shaken and left to stand at room temperature for 10 min. The absorbance of the solution was thereafter measured at 562 nm.

Anti-inflammatory activity

RAW 264.7, a murine monocyte/macrophage cell line, was grown in DMEM medium supplemented with 10% defined FBS and 1% penicillin G-streptomycin in an atmosphere containing 5% CO2/95% air at 37°C. The macrophages were seeded in 12-well plates (1×106 cells/well) using fresh medium. After preincubation for 24 h, plates were cotreated with LPS at 100 ng/ml and 2 different concentrations of the drugs (100μg/ml and 50 μg/ml) in DMEM without FBS for 24 h (for RNA extraction and COX-2 activity).

PGE2 immunoassay

PGE2 amounts in culture medium were quantified in supernatants by enzyme immune assay using ELISA kits (R&D Systems), following manufacturer’s guidelines.

Cell viability

Jurkat cells, corresponding to human leukemic T cell line, were seeded in 96-well plates (8×103 cells/well). The following day, cells were treated with the different extracts at concentrations ranging from 5 to 200 μg/ml for 24, 48, and 72 h and cell viability was detected using Cell Proliferation Assay, XTT (Gentaur, Belgium) as previously described [25]. The XTT (sodium 3′-1 (phenylaminocarbonyl)-3,4-tetrazolium-bis (4-methoxy- 6-nitro) benzene sulfonic acid) cell proliferation assay is an effective method to measure cell growth and drug sensitivity in tumor cell lines. XTT is a colorless or slightly yellow compound that when reduced becomes bright orange. Briefly, XTT is cleaved by the mitochondrial dehydrogenase in metabolically active living cells to form an orange formazan dye. The absorbance of each sample was measured with a spectrophotometer at a wavelength of 450 nm.

Quantitative real-time PCR

Total RNA was extracted with Trizol reagent according to the manufacturer’s guidelines (Invitrogen, Merelbeke, Belgium) and first-strand cDNAs were synthesized by reverse transcription (Superscript First-strand Synthesis System for RT-PCR kit; Invitrogen, Merelbeke, Belgium). Quantitative mRNA expression for the different genes was measured by real-time PCR with the PRISM 7900 sequence detection system (Applied Biosystems, Gent, Belgium), and the SYBR Green Master mix kit with β-actin mRNA was used as an internal control. The primers used for the amplification of each of the genes are indicated in Table 5. The program used for amplification was: 10 min at 95°C followed by 40 cycles of 15 s at 95°C and 1 min at 60°C. All qPCR reactions were performed in triplicate. The expression levels (2−ΔΔCt) of mRNAs were calculated as described previously [26].
Table 5

List of primers used in this study.

PrimersSequence (5′-3′)
IL-1α-FOGAATGACgCCCTCAATCAAAGT
IL-1α-RETCATCTTGGGCAGTCACATACA
IL-1β-FOCCTTCCAGGATGAGGACATGA
IL-1β-RETGAGTCACAGAGGATGGGCTC
IL-6-FOGAGGATACCACTCCCAACAGACC
IL-6-REAAGTGCATCATCGTTGTTCATACA
CCL3-FOCAGCCAGGTGTCATTTTCCT
CCL3-RECTGCCTCCAAGACTCTCAGG
CCL4-FOAAAACCTCTTTGCCACCAATACC
CCL4-REGAGAGCAGAAGGCAGCTACTAG
COX2-FOCAGACAACATAAACTGCGCCTT
COX2-REGATACACCTCTCCACCAATGACC
iNOS-FOGCAGAATGTGACCAT CATGG
iNOS-REACAACCTTG GTGTTGAAG GC

Statistical analysis

The data are presented as means ±SEM of at least 3 independent experiments and analyzed using Student’s t-test to determine any differences between group means, using SPSS for Windows (Version 21). P-Values <0.05 (*), <0.01 (**), <0.001 (***) were considered significant.

Results

Phytochemical screening of the leaves of Crataegus azarolus L

Phytochemical screening of C. azarolus L. fresh leaf crude extract indicated the presence of some important bioactive components, which are listed in Table 6. The aqueous crude extract showed high concentrations of saponins, phenols, terpenoids, flavonoids, amino acids, reducing sugars, and lignin; moderate concentrations of cardiac glycosides; low concentrations of resins, carbohydrates, phlobatannins, and flavones; and absence of alkaloids, tannins, quinone, coumarin, sterols/steroids, diterpenes, anthraquinones, anthocyanin, and fixed oils and lipids. On the other hand, the methanolic crude extract showed high abundance of alkaloids, resins, phenol, quinones, diterpenes, and lignin; moderate abundance of sterols/steroids; low abundance of flavonoids, carbohydrates, cardiac glycosides, reducing sugars, phlobatannins and flavones; and absence of tannins, saponins, terpenoids, coumarin, amino acids, anthraquinones, anthocyanin, and fixed oils and lipids. The ethanolic crude extract exhibited high amounts of resins, phenol, quinones, diterpenes and lignin; moderate amounts of sterols/steroids; low amounts of alkaloids, flavonoids, cardiac glycosides and flavones; and absence of tannins, saponins, terpenoids, coumarin, carbohydrates, amino acids, anthraquinones, reducing sugars, phlobatannins, anthocyanin, and fixed oils and lipids. Altogether, these observations indicate that the different solvents used had preferential extraction of some phytochemicals from C. azarolus leaves.
Table 6

Phytochemical screening of C. azarolus. L. leaf extracts. Key: −, absent; +, low in abundance; ++, moderate in abundance; +++, high in abundance.

AqueousMethanolEthanol
Alkaloids++++
Tannins
Resins+++++++
Saponins+++
Phenol+++++++++
Terpenoids+++
Flavonoids+++++
Quinones++++++
Coumarin
Carbohydrates++
Amino acids+++
Sterols + Steroides++++
Cardiac Glycosides++++
Diterpenes++++++
Anthraquinones
Reducing sugars++++
Phlobatannins++
Anthocyanins
Flavones+++
Lignin+++++++++
Fixed oil + Lipids

GC/MS Analysis of essential oil obtained from the C. azarolus. L leaf extracts

The GC spectrum of the water, ethanolic, and methanolic extracts are shown in Figures 1–3, respectively. A total of 11 compounds present in the water extract, 7 compounds present in the ethanolic extract, and 8 compounds present in the methanolic extract were determined by the chromatographic method with the help of NIST and WILEY library as shown in Tables 7–9, respectively. In the case of water extract, pluchidiol compound was found to be in the highest concentration (33.62%) and other compounds were found in trace amounts (Table 7). In the case of ethanolic extract, γ-tocopheryl methyl compound was found to be in the highest concentration (43.73%) followed by phytol isomer (20.47%), and other compounds were found in trace amounts (Table 8). In the case of methanolic extract, α tocopherol-beta-d-mannoside (21.87%), and ethyl linolinate (18.79%) compounds were found to be in the highest concentration and other compounds were found in trace amounts (Table 9).
Figure 1

GC chromatogram of the water extract of C. azarolus L. leaf.

Figure 2

GC chromatogram of the ethanol extract of C. azarolus L. leaf.

Figure 3

GC chromatogram of the methanol extract of C. azarolus L. leaf.

Table 7

Results of the GC-MS analysis of the water extract of the C. azarolus. L. leaf.

Peak#RTNameMWStructureMolecular formulaArea %
110.507Epoxylinalol170.25 C10H18O24.73
213.324Isophytol296.54 C20H40O3.03
313.584Syringol154.163 C8H10O30.58
413.7548-Hydroxylinalool170.24 C10H18O21.46
516.1062,4- DI-T-Butylphenol206.324 C14H22O0.85
619.2404-Oxo-Beta-Isodamascol208.297 C13H20O23.04
719.422Gamma-Hydroxyisoeugenol (Coniferol)180.201 C10H12O32.35
819.811Gallic acid trimethyl ether212.2 C10H12O52.82
920.204Pluchidiol208-----C13H20O233.62
1020.483Beta-Hydroxypropiovanillone196.202 C10H12O42.16
1127.663Trichothecin332.39 C19H24O55.67
Table 8

Results of the GC-MS analysis of the ethanol extract of the C. azarolus. L. leaf.

Peak#RTNameMWStructureMolecular formulaArea%
152.169Palmitic acid256.42 C16H32O23.99
256.691Phytol Isomer296.53 C20H40O20.47
357.4409,12,15-Octadecatrienoic acid278.436 C18H30O27.44
458.077Stearic acid284.48 C18H36O20.95
581.175Gamma-Tocopheryl methyl416.69 C28H48O243.73
684.651Gamma-Sitosterol414.71 C29H50O19.2
785.572Cedryl acetate264.41 C17H28O20.72
Table 9

Results of the GC-MS analysis of the methanol extract of the C. azarolus. L.leaf.

Peak#RTNAMEMWStructureMolecular formulaArea%
16.859Oxalic acid dimethyl ester118.09 C4H6O41.58
230.027Syringol184.19 C9H12O41.62
336.5972,4 di-tert-butylphenol206.324 C14H22O1.51
452.103Cetylic acid256.42 C16H32O22.56
556.738Phytol296.53 C20H40O13.3
657.388Ethyl linolinate308.50 C20H34O218.79
761.9174,4′-biguaiacol246.26 C14H14O41.37
881.133alpha-tocopherol-beta-d-mannosid592.858 C35H60O721.87

The LC/MS/MS analysis for C. azarolus L leaf extracts

The LC spectrum results of the C. azarolus leaf extracts are shown in Table 10. A total of 2, 6, and 6 compounds were present in the water, ethanolic, and methanolic extracts, respectively, were determined by the chromatographic method based on the retention time and mass characteristics.
Table 10

Results of LC/MS/MS technique of C. azarolus. L. leaf.

C. azarolus L.Compounds namesRetention timeQ1 Mass (Da)Q3 Mass (Da)CEDP (V)
WaterVitexin4.96431341−30−40
Hyperoside4.97463301−38−40
EthanolPrunin5.23433271−20−40
Quercetin5.87301179−35−40
Rutin4.89609301−35−40
Vitexin4.94431341−30−40
Hyperoside4.99463301−38−40
Isoorientin4.88447429−30−40
MethanolPrunin5.23433271−20−40
Quercetin5.88301179−35−40
Rutin4.89609301−35−40
Vitexin4.94431341−30−40
Hyperoside4.99463301−38−40
Isoorientin4.88447429−30−40

Antioxidant activity of C. azarolus L leaf extracts

The antioxidant activity of the aqueous, methanolic and ethanolic crude extracts was evaluated using 2 different assays: (1) DPPH free radical scavenging assay and (2) an assay assessing the iron (II) chelating ability. Our obtained results demonstrated that the different extracts displayed significant antioxidant activities and their scavenging effects on DPPH radical were in the following order: ethanolic extract (IC50=50±5.2 μg/ml) >methanolic extract (IC50=55±2.8 μg/ml) > water extract (IC50=60±2.2 μg/ml) (Table 11).
Table 11

DPPH free scavenging capacity (IC50, μg/ml) and Ferrous-ion (Fe2+) chelating ability (IC50, mg/ml) of aqueous, methanol or ethanol extracts derived from fresh C. azarolus leaves. IC50 value corresponds to the effective concentration of sample required to scavenge DPPH radical or Ferrous-ion by 50%. Each value represents a mean ±SD (n=3).

DPPH assayFe2+ chelating assay
ExtractIC50, μg/mlIC50, mg/ml
Fresh leavesAqueous60±2.281.5±0.07
Methanol55±2.8860.5±0.08
Ethanol50±5.2071±0.08
Ferrous ion (Fe2+) is a major preoxidant that upon interaction with hydrogen peroxide can lead to the generation of highly reactive hydroxyl radicals. The Fe2+ chelating assay is based on the principle that ferrozine can quantitatively form colored complexes with Fe2+. However, when other chelating agents are present, the complex formation is disrupted and the extent of color reduction allows determination of the chelating activity of the coexisting chelator. Using the Fe2+ chelating assay, the antioxidant potential of aqueous, methanolic, and ethanolic crude extracts derived from fresh leaves was assessed upon determination of their abilities to bind Fe2+ in the presence of ferrozine. Methanolic extract had the highest Fe2+ chelating capacity (IC50=0.5±0.08 mg/ml), followed by ethanolic extract (IC50=1±0.08 mg/ml) and then aqueous extract (IC50=1.5±0.07 mg/ml) (Table 11). Our observations indicate that the alcoholic extracts show more efficient antioxidant capacity than aqueous extract.

Anti-inflammatory activity of C. azarolus leaf extracts

Inflammatory response is a host’s defensive mechanism against pathogens and is triggered by various microbial products such as lipopolysaccharide (LPS) [27]. Among the most important immune cells involved in this process are macrophages. Indeed, LPS can stimulate macrophages to produce large amounts of proinflammatory cytokines (such as IL-1α, IL-1β, and IL-6) and chemokine (including CCL3 and CCL4) [27] as well as other proinflammatory mediators including nitric oxide (NO) and prostaglandin E2 (PGE2) that are fabricated by the inflammation-inducible isoforms of NO synthase (iNOS) and cyclooxygenase-2 (COX-2) enzymes [28,29]. To assess the potential anti-inflammatory properties of C. azarolus. L leaf extracts, RAW 264.7 murine macrophage cells were used. These are capable of producing PGE2 upon stimulation with LPS. Cells were treated for 24 h with either LPS (100 ng/ml) alone (control) or LPS together with different concentrations (50 or 100 μg/ml) of aqueous, methanolic, and ethanolic crude extracts derived from fresh leaves. In a first step, and upon using quantitative real-time PCR (qRT-PCR), relative iNOS and COX-2 mRNA levels in leaf extract-treated RAW264.7 cells versus non-treated control cells were determined. In the case of COX-2, 100 μg/ml of aqueous extract were required to trigger about 50% reduction in mRNA levels (Figure 4A). Ethanolic and methanolic extracts were more potent in terms of inhibition of COX-2 transcription since 50 μg/ml of either extract was sufficient to reduce COX-2 mRNA levels by about half (Figure 4A). Interestingly, COX-2 transcription was nearly lost upon treating cells with 100 μg/ml of either ethanolic or methanolic extract (Figure 1A). In the case of iNOS, the 3 different extracts exhibited high efficiency in terms of impairing iNOS transcription, with ethanolic extract being the most potent, followed by methanolic extract and then aqueous extract (Figure 4B).
Figure 4

Effects of C. azarolus leaf extracts on LPS-Induced iNOS, COX-2, PGE2, IL-1α, IL-1-β, IL-6, CCL3, and CCL4 levels in RAW 264.7 cells. Cells were treated for 24 h with 100 ng/ml LPS in the absence or presence of 50 or 100 μg/ml of either aqueous (A), ethanol (E), or methanol (M) extract. Total RNA was prepared and qRT-PCR was performed to quantify the mRNA levels of COX2 (A), iNOS (B), IL-1α (D), IL-1β (E), IL-6 (F), CCL3 (G), and CCL4 (H). The presented data correspond to the relative mRNA levels (values obtained in: RAW 264.7 cells treated with both LPS and extract/RAW 264.7 cells treated with only LPS). (C) Cell-free supernatants were collected and assayed for PGE2 content via ELISA. The data correspond to the relative percentage of PGE2. Reported values represent the averages ±SEM of 3 independent experiments (n=3) each done in triplicate. * p<0.05; ** p<0.01, *** p<0.001 vs. control untreated cells (Student’s t-test).

In a second step, and upon using ELISA technique, relative PGE2 amounts present in the cell culture media were evaluated. Interestingly, all extracts were highly potent in terms of impairing PGE2 production, with methanolic extract being the most efficient (Figure 4C). In a third step, and upon using qRT-PCR, the relative expression of the proinflammatory cytokines IL-1α, IL-1β, and IL-6 was assessed. In the case of IL-1α, neither of the 2 utilized aqueous extract concentrations was able to significantly impair IL-1α transcription (Figure 4D). On the other hand, 100 μg/ml of either ethanolic or methanolic extract dramatically reduced IL-1α mRNA levels (Figure 4D). For IL-1β, aqueous extract was again not efficient in terms of reducing the mRNA levels (Figure 4E). On the other hand, 100 μg/ml of ethanolic extract reduced IL-1β mRNA levels to less than half their level in control cells (Figure 4E). Methanolic extract was more efficient in impairing IL-1β transcription, since minimal IL-1β mRNA levels were detected in cells treated with 100 μg/ml of methanol extract (Figure 4E). In the case of IL-6, no striking alteration in mRNA levels was detected in cells treated with 50 μg/ml or 100 μg/ml aqueous extract (Figure 4F). IL-6 mRNA levels were not largely reduced in cells treated with 50 μg/ml of ethanolic extract but was lost following treatment with 100 μg/ml (Figure 4F). The effect of methanolic extract was more robust since about 75% of IL-6 mRNA amount was lost in cells treated with 50 μg/ml (Figure 4F). IL-6 transcription was lost in cells treated with 100 μg/ml of methanolic extract (Figure 4F). In a fourth step, qRT-PCR was carried out to determine the transcription profiles of the proinflammatory chemokines CCL3 and CCL4. These 2 chemokines exhibited comparable transcription profiles under the different studied conditions (Figure 4G, 4H). Neither CCL3 nor CCL4 transcription was lowered following treatment with either concentration of aqueous extract (Figure 4G, 4H). Where no reduction in neither CCL3 nor CCL4 transcription was detected upon treating cells with 50 μg/ml of either ethanolic or methanolic extract, 100 μg/ml of the ethanolic extract reduced the mRNA levels of either chemokine by about 30%, and 100 μg/ml of methanolic extract decreased the mRNA levels by about 75% (Figure 4G, 4H).

Antiproliferative activity of Crataegus azarolus L. leaf extracts

To determine if C. azarolus L leaf extracts affect cell viability, the XTT assay was carried out. This is a colorimetric assay during which the yellow water-soluble substrate XTT is reduced to a highly colored formazan product by succinate dehydrogenase enzymes in metabolically active cells. This conversion takes place only in viable cells; therefore, the amount of the formed formazan is proportional to the concentration of viable cells in the sample. Jurkat cancer cells were treated with different concentrations (5–200 μg/mL) of either aqueous, methanolic, or ethanolic crude extracts for different periods of time (24, 48, or 72 h). The aqueous extract exerted no significant effect on cell viability in all tested conditions (Figure 5A), while ethanolic and methanolic extracts exerted dose- and time-dependent inhibitory effects (Figure 5B, 5C). In the case of ethanolic extracts, the IC50 value (dose required to inhibit cell growth by 50%) corresponded to 150±4.4 μg/ml after 24 h (Figure 5B), and prolonged treatment for 48 h and 72 h caused a more striking inhibition of cell growth, as the IC50 values were 25±1.6 μg/ml and 15±2.88 μg/ml, respectively (Figure 5B). Methanolic extract showed a more potent inhibitory effect than ethanolic extract; after 24 h of treatment with methanolic extract, the IC50 value corresponded to only 50 μg/ml and prolonged treatment reduced this value to 22±1.6 μg/ml (after 48 h) and 13±1.8 μg/ml (after 72 h) (Figure 5C).
Figure 5

Effects of C. azarolus L leaf extracts on Jurkat cancer cell proliferation. Cells were treated with various concentrations (0, 5, 25, 50, 100, 200 μg/ml) of extracts for 24, 48, and 72 h and antiproliferative activities were measured by XTT assay. Each value represents a mean ± SEM for 3 independent experiments (n=3) each done in triplicate. Fresh leaf-derived aqueous extract (A), ethanol extract (B), and methanol extract (C). * p<0.05; ** p<0.01, *** p<0.001 vs. control untreated cells (Student’s t-test).

Discussion

Plants have been used throughout history to cure human diseases. Worldwide, people still use medicinal plants for healing and relieving physical suffering. Many modern medicines have been derived either directly or indirectly from medicinal plants [30]. Many studies still focus on identifying new medicinal plants. In this study, we identified the chemical content of Crataegus azarolus L leaf extracts and assessed their therapeutic value. Interestingly, our phytochemical analysis showed the presence of various important medicinal components in the tested plant, including alkaloids, resins, phenol, quinones, diterpenes, lignin, sterols/steroids, flavonoids, carbohydrates, cardiac glycosides, reducing sugars, phlobatannins, and flavones. In agreement with previous observations [31-33], our data showed that the alcoholic solvents (ethanol and methanol) were more efficient than the aqueous one in extracting those bioactive compounds. Identifying such important medicinal components in C. azarolus species is not surprising since various Crataegus species studied so far contained valuable therapeutic chemical compounds and are widely used in clinical applications [23]. Despite the identified chemical components, the Lebanese Crataegus azarolus L plant could carry much more compounds in them. In this study, different parameters account for the limited number of identified components. For instance, the output of the GC/MS analysis, aimed to identify essential oils, is affected by the type of solvent used during the extraction method. Moreover, the limited number of chemical elements identified by LC/MS/MS analysis is due to the fact that this analysis was targeted towards only 11 flavonoid compounds, and the presence/absence of many other elements was not checked. Further, the chemical composition of this plant could also be affected by environmental and geographical parameters, including the year and the season of harvest, exposure to sunlight, the altitude, and the region where the plant was harvested. To characterize the medicinal potential of the Lebanese C. azarolus species, we determined their antioxidant, anti-inflammatory, and antiproliferative effects. Oxidative stress occurs when the number of free radicals and reactive biomolecules in a body exceeds the body’s ability to neutralize and eliminate them. Oxidative stress has deleterious effects on human health since it forms the basis for a variety of critical diseases affecting the heart, brain, kidney, liver, lungs, eyes, blood, skin, and joints [34]. Identifying new natural antioxidants is therefore highly valuable. In this study, 2 different methods, DPPH-scavenging ability and Fe2+-chelating activity assays, identified an antioxidant potential of C. azarolus extracts, with varied efficiency according to the type of used solvent. Indeed, and in both assays, extracts prepared using the alcoholic solvents showed more potent antioxidant activity than aqueous extracts. This could be related to the prominent chemical content in the alcohol- vs. water-prepared extracts. In addition to their cytotoxic effect, the reactive biomolecules might also trigger the initiation and/or amplification of inflammation via upregulation of different genes encoding for proinflammatory cytokines and molecules. Inflammation is believed to be associated with nearly all known chronic diseases, including heart diseases, diabetes, neurodegenerative disorders, autoimmune pathologies, and cancer [27,35]. Suppression of the inflammatory responses is therefore indispensable for treating these diseases. Interestingly, in the present study we evaluated the inhibitory potential of the indicated plant on both the secreted amounts of PGE2 and the transcription levels of the proinflammatory cytokines (IL-α, IL-β and Il-6) and chemokines (CCL3 and CCL4), as well as COX-2 and iNOS enzymes. The different plant extracts showed varied anti-inflammatory capacities in a manner dependent on the type of solvent. Although the aqueous extract showed only moderate anti-inflammatory capacity, the alcoholic extracts strongly suppressed all of the mentioned proinflammatory mediators, with methanolic extract being more efficient than ethanolic extract. This robust anti-inflammatory potential is in agreement with their chemical arsenal and antioxidant activity. Crataegus azarolus L leaves could be then used to treat inflammatory diseases or serve as a promising resource for developing inflammatory-suppressive drugs. In this study, the antiproliferative activity of the different extracts from leaves of Crataegus azarolus L was investigated in Jurkat cancer cells by XTT viability assay. In contrast to the aqueous extract, which failed to inhibit Jurkat cells proliferation, the alcoholic extracts substantially suppressed cell growth, with methanolic extract showing a more potent suppressive capacity than ethanolic extract. This inhibitory effect was time- and dose-dependent. The rich phytochemical arsenal identified in the alcoholic extracts might explain their robust antiproliferative potential. However, the molecular mechanisms accounting for this cytotoxicity are still unclear. Whether components of the apoptotic pathway are involved remains to be investigated. Moreover, whether Crataegus azarolus L leaf extracts could suppress the proliferation of different cancer cell types will be addressed in our future work.

Conclusions

In conclusion, the present study revealed the presence of different medicinal compounds in the leaves of Lebanese Crataegus azarolus L. Due to its substantial antioxidant, anti-inflammatory, and antiproliferative activities, this plant might offer a novel promising therapy that is beneficial for general health.
  32 in total

1.  Several culinary and medicinal herbs are important sources of dietary antioxidants.

Authors:  Steinar Dragland; Haruki Senoo; Kenjiro Wake; Kari Holte; Rune Blomhoff
Journal:  J Nutr       Date:  2003-05       Impact factor: 4.798

Review 2.  Regulation of autophagy by ROS: physiology and pathology.

Authors:  Ruth Scherz-Shouval; Zvulun Elazar
Journal:  Trends Biochem Sci       Date:  2010-08-20       Impact factor: 13.807

Review 3.  Prostaglandins and cancer.

Authors:  D Wang; R N Dubois
Journal:  Gut       Date:  2005-08-23       Impact factor: 23.059

Review 4.  Anti-inflammatory bioactivities in plant extracts.

Authors:  R S Talhouk; C Karam; S Fostok; W El-Jouni; E K Barbour
Journal:  J Med Food       Date:  2007-03       Impact factor: 2.786

5.  Analyzing real-time PCR data by the comparative C(T) method.

Authors:  Thomas D Schmittgen; Kenneth J Livak
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

6.  Molecular regulation of catechins biosynthesis in tea [Camellia sinensis (L.) O. Kuntze].

Authors:  Arti Rani; Kashmir Singh; Paramvir S Ahuja; Sanjay Kumar
Journal:  Gene       Date:  2011-12-29       Impact factor: 3.688

Review 7.  Role of oxygen radicals in DNA damage and cancer incidence.

Authors:  Marian Valko; Mario Izakovic; Milan Mazur; Christopher J Rhodes; Joshua Telser
Journal:  Mol Cell Biochem       Date:  2004-11       Impact factor: 3.396

8.  Anti‑inflammatory and anti‑proliferative effects of Rhus verniciflua Stokes in RAW264.7 cells.

Authors:  Han-Seok Choi; Hye Sook Seo; Soon Re Kim; Youn Kyung Choi; Bo-Hyoung Jang; Yong-Cheol Shin; Seong-Gyu Ko
Journal:  Mol Med Rep       Date:  2013-11-04       Impact factor: 2.952

Review 9.  The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment.

Authors:  Alexander Greenhough; Helena J M Smartt; Amy E Moore; Heather R Roberts; Ann C Williams; Christos Paraskeva; Abderrahmane Kaidi
Journal:  Carcinogenesis       Date:  2009-01-09       Impact factor: 4.944

10.  Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines.

Authors:  D A Scudiero; R H Shoemaker; K D Paull; A Monks; S Tierney; T H Nofziger; M J Currens; D Seniff; M R Boyd
Journal:  Cancer Res       Date:  1988-09-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.